Sort
172,184 grants matching “inflammation”
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
$715,988Namita Rout · Tulane University Of Louisiana · R01 · FY2022 · DK
Determining drivers of mast cell expansion and function during human airway disease
$715,968Daniel F Dwyer · Brigham And Women'S Hospital · R01 · FY2024 · HL
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes-Texas Children's Center.
$715,946Fida Bacha · Baylor College Of Medicine · U01 · FY2024 · DK
Bioresorbable zinc-based drug-eluting stents for pediatric cardiovascular applications
$715,928Donghui Zhu · State University New York Stony Brook · R01 · FY2025 · HL
The Protective and Pathologic Features of the EVD Survivor Immune System
$715,921William Fischer · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Inflammasome activation in an SIV-ART model of chronic drug abuse
$715,886Janice Ellen Clements · Johns Hopkins University · R01 · FY2019 · DA
New Molecular Targets in Pulmonary Fibrosis
$715,825University Of Pittsburgh At Pittsburgh · R01 · FY2005 · HL
Impact of hypertension and aging on postoperative delirium
$715,801Niccolo Terrando · Duke University · R01 · FY2025 · AG
Tissue resident memory T cells and chronic lung allograft dysfunction
$715,793Mark Eugene Snyder · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Novel ISH Approaches to Quantify Replication Competent Reservoirs
$715,742Jacob D Estes · Oregon Health & Science University · R01 · FY2021 · AI
Investigating neurobehavioral consequences of COVID-19 related stressors on maternal mental health and infant development
$715,736Natalie Hiromi Brito · New York University · R01 · FY2024 · MH
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
$715,709Clayton E Mathews · University Of Florida · R01 · FY2023 · DK
Dopamine function, inflammation and connectivity in PTSD
$715,697James Douglas Bremner · Emory University · R01 · FY2022 · MH
Developing the Dietary Inflammatory Index for Clinical Application
$715,682Nitin Shivappa · Connecting Health Innovations, Llc · R44 · FY2015 · DK
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease
$715,659Jeanie Park · Emory University · R01 · FY2022 · HL
Novel Therapeutics for Cardiovascular Disease
$715,647Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2022 · HL
Application of Implementation Science approaches to assess the effectiveness of Task-shifted WHO-PEN to address cardio metabolic complications in people living with HIV in Zambia
$715,645Wilbroad Mutale · Centre For Infectious Disease Research · UG3 · FY2020 · HL
THE GENETICS AND MULTI-OMICS SPECIMENS CORE (GMSC)
$715,632Carlos Cruchaga · Washington University · U19 · FY2022 · AG
Dose-Response to Resistance Exercise on Cardiovasular Health
$715,566Duck-Chul Lee · Iowa State University · R01 · FY2024 · HL
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
$715,557Jacqueline Kerr · University Of California, San Diego · R01 · FY2014 · CA
Epigenetic markers of severity in nonalcoholic fatty liver disease
$715,550Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2019 · DK
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$715,549Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events
$715,543Adam Mor · Columbia University Health Sciences · R01 · FY2025 · AI
Interruption of maternal-fetal transmission of HIV
$715,530Joseph M McCune · University Of California, San Francisco · R01 · FY2012 · AI
T helper cells and stem cells in colon homeostasis and tumor initiation
$715,501Arnold Han · Columbia University Health Sciences · R01 · FY2025 · DK